CGT, Medical Device and Ocular Safety Assessment Services

Pharmaron’s special safety assessment services cover CGT, ocular and medical device products. These three types of medical modalities are unique with respect to in-life techniques, bioanalytical methodologies and regulatory requirements in safety assessment, in comparison to other test articles.

Over the years, Pharmaron has established comprehensive and end-to-end safety assessment platforms tailored to address the unique needs of the products of CGT, ocular and medical devices. The teams have an excellent track record in the delivery of high-quality safety assessment studies to support regulatory submissions, to FDA, EMA and NMPA.  For other general safety assessment services, please click here.